Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer von BRAVE, Sandra R, ODEDRA, Rajesh, WAINWRIGHT, Anna, LOVICK, Susan C, MARK HICKINSON, D, WILKINSON, Robert W, BARRY, Simon T, SPEAKE, Georgina, RYAN, Anderson J, JAMES, Neil H, SMITH, NeilR, MARSHALL, Gayle B, ACHESON, Kerry L, BAKER, Dawn, HOWARD, Zoe, AY JACKSON, Lyns, RATCLIFFE, Kirsty

Volltext

Identification of Biomarkers in Human Head and Neck Tumor Cell Lines That Predict For In Vitro Sensitivity to Gefitinib von Hickinson, D. Mark, Marshall, Gayle B., Beran, Garry J., Varella-Garcia, Marileila, Mills, Elizabeth A., South, Marie C., Cassidy, Andrew M., Acheson, Kerry L, McWalter, Gael, McCormack, Rose M., Bunn, Paul A., French, Tim, Graham, Alex, Holloway, Brian R., Hirsch, Fred R., Speake, Georgina

Volltext